8-K//Current report
Ultragenyx Pharmaceutical Inc. 8-K
Accession 0000950170-22-012192
$RARECIK 0001515673operating
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 4:12 PM ET
Size
186.3 KB
Accession
0000950170-22-012192
Documents
- 8-Krare-20220624.htmPrimary
8-K
- EX-101.LABrare-20220624_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
- EX-101.PRErare-20220624_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
- EX-101.SCHrare-20220624.xsd
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLrare-20220624_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0000950170-22-012192-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001515673
Filing Metadata
- Form type
- 8-K
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 4:12 PM ET
- Size
- 186.3 KB